AMICUS THERAPEUTICS, INC. Quarterly Goodwill in USD from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Amicus Therapeutics, Inc. quarterly Goodwill history and growth rate from Q4 2013 to Q3 2024.
  • Amicus Therapeutics, Inc. Goodwill for the quarter ending September 30, 2024 was $198M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $198M $0 0% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $198M $0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $198M $0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $198M $0 0% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $198M $0 0% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $198M $0 0% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $198M $0 0% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $198M $0 0% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $198M $0 0% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $198M $0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $198M $0 0% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $198M -$3K 0% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $198M $0 0% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $198M $0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $198M $0 0% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $198M $0 0% Dec 31, 2020 10-K 2023-03-01
Q3 2020 $198M $0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $198M $0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $198M $0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $198M $0 0% Dec 31, 2019 10-K 2022-02-24
Q3 2019 $198M $0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $198M $0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $198M $0 0% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $198M +$3K +0% Dec 31, 2018 10-K 2021-03-01
Q3 2018 $198M -$3K 0% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $198M $0 0% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $198M $0 0% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $198M $0 0% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $198M +$3K +0% Sep 30, 2017 10-K 2020-03-02
Q2 2017 $198M $0 0% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $198M $0 0% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $198M $0 0% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $198M -$9.77M -4.71% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $198M +$186M +1603% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $198M +$186M +1603% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $198M +$186M +1603% Dec 31, 2015 10-K/A 2017-03-03
Q3 2015 $208M +$196M +1687% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $11.6M $0 0% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $11.6M $0 0% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $11.6M $0 0% Dec 31, 2014 10-K 2016-02-29
Q3 2014 $11.6M Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $11.6M Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $11.6M Mar 31, 2014 10-Q 2014-05-05
Q4 2013 $11.6M Dec 31, 2013 10-K 2015-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.